Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mora, M.
Right arrow Articles by Engel, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mora, M.
Right arrow Articles by Engel, A. G.
NEUROLOGY 1987;37:206
© 1987 American Academy of Neurology

Synaptic vesicle abnormality in familial infantile myasthenia

Marina Mora, PhD, Edward H. Lambert, MD, PhD and Andrew G. Engel, MD

Department of Neurology and Neuromuscular Research Laboratory, Mayo Clinic, Rochester, MN.

In familial infantile myasthenia (FIM) the miniature end-plate potential (MEPP) amplitude is normal in rested muscle, but stimulation in vitro at 10 Hz decreases it abnormally, and neuromuscular transmission fails in a few minutes. In search of a morphologic correlate of the transmission failure, we analyzed the densities and diameters of synaptic vesicles in deep and superficial regions of nerve terminals in external intercostal muscles of three FIM patients and three nonweak controls before and after 10-Hz stimulation for 10 minutes. The densities of superficial or deep synaptic vesicles before or after stimulation in FIM were not significantly different from the corresponding control values. The diameters of superficial and deep synaptic vesicles before stimulation were significantly smaller in the three FIM patients than in the three controls. Stimulation in the FIM patients reduced the MEPP amplitude by 51 to 75%, but increased the vesicle diameter in two patients and did not change the vesicle diameter in one patient. Stimulation in the controls reduced the MEPP amplitude by only 16 to 34%, decreased the vesicle diameter in two, and did not change the vesicle diameter in one. Stimulation after treatment with 1 mg/dl hemicholinium markedly reduced the MEPP amplitude in the controls, had no further effect on the transmission defect in FIM, and had no consistent effect on vesicle diameter in FIM or controls. We conclude that synaptic vesicles are abnormally small in rested muscle in FIM, but vesicle size cannot be reliably correlated with the MEPP amplitude in FIM or controls.

Address correspondence and reprint requests to Dr. Engel, Mayo Clinic, Rochester, MN 55905.

Supported hy NIH Grant NS6277, by a Research Center Grant from the Muscular Dystrophy Association, and by the Mogg Fund.

Received April 21, 1986. Accepted for publication May 20, 1986.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Tsujino, C. Maertens, K. Ohno, X.-M. Shen, T. Fukuda, C. M. Harper, S. C. Cannon, and A. G. Engel
Myasthenic syndrome caused by mutation of the SCN4A sodium channel
PNAS, June 10, 2003; 100(12): 7377 - 7382.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. Kraner, I. Laufenberg, H. M. Strassburg, J. P. Sieb, and O. K. Steinlein
Congenital Myasthenic Syndrome With Episodic Apnea in Patients Homozygous for a CHAT Missense Mutation
Arch Neurol, May 1, 2003; 60(5): 761 - 763.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
R. A. Maselli, D. Z. Kong, C. M. Bowe, C. M. McDonald, W. G. Ellis, M. A. Agius, C. M. Gomez, D. P. Richman, and R. L. Wollmann
Presynaptic congenital myasthenic syndrome due to quantal release deficiency
Neurology, July 24, 2001; 57(2): 279 - 289.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Ohno, A. Tsujino, J. M. Brengman, C. M. Harper, Z. Bajzer, B. Udd, R. Beyring, S. Robb, F. J. Kirkham, and A. G. Engel
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans
PNAS, February 13, 2001; 98(4): 2017 - 2022.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Abicht, R. Stucka, V. Karcagi, A. Herczegfalvi, R. Horvath, W. Mortier, U. Schara, V. Ramaekers, W. Jost, J. Brunner, et al.
A common mutation ({epsilon}1267delG) in congenital myasthenic patients of Gypsy ethnic origin
Neurology, October 22, 1999; 53(7): 1564 - 1564.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. Middleton, K. Ohno, K. Christodoulou, J. Brengman, M. Milone, V. Neocleous, P. Serdaroglu, F. Deymeer, C. Ozdemir, A. Mubaidin, et al.
Chromosome 17p-linked myasthenias stem from defects in the acetylcholine receptor {epsilon}-subunit gene
Neurology, September 1, 1999; 53(5): 1076 - 1076.
[Abstract] [Full Text]

Home page
 NeuroscientistHome page
A. G. Engel, K. Ohno, H.-L. Wang, M. Milone, and S. M. Sine
REVIEW {blacksquare} : Molecular Basis of Congenital Myasthenic Syndromes: Mutations in the Acetylcholine Receptor
Neuroscientist, May 1, 1998; 4(3): 185 - 194.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
J. S. Janas and R. J. Barohn
A Clinical Approach to the Congenital Myasthenic Syndromes
J Child Neurol, March 1, 1995; 10(2): 168 - 169.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by AAN Enterprises, Inc.